Join the Zyprexa group to help and get support from people like you.
Zyprexa News
FDA Medwatch Alert: Olanzapine: Drug Safety Communication - FDA Warns About Rare But Serious Skin Reactions
ISSUE: FDA is warning that the antipsychotic medicine olanzapine can cause a rare but serious skin reaction that can progress to affect other parts of the body. FDA is adding a new warning to the...
FDA Medwatch Alert: Zyprexa Relprevv (olanzapine pamoate): Drug Safety Communication - FDA Review of Study Sheds Light on Two Deaths Associated with the Injectable Schizophrenia Drug
ISSUE: FDA has concluded a review of a study undertaken to determine the cause of elevated levels of the injectable schizophrenia drug Zyprexa Relprevv (olanzapine pamoate) in two patients who died....
FDA Medwatch Alert: Zyprexa Relprevv (Olanzapine Pamoate): Drug Safety Communication - FDA Investigating Two Deaths Following Injection
ISSUE: FDA is investigating two unexplained deaths in patients who received an intramuscular injection of the antipsychotic drug Zyprexa Relprevv (olanzapine pamoate). The patients died 3-4 days ...
FDA Approves Lilly's Zyprexa Relprevv for Treatment of Schizophrenia in Adults
INDIANAPOLIS, Dec. 14 /PRNewswire-FirstCall/ – The U.S. Food and Drug Administration (FDA) approved Zyprexa Relprevv (olanzapine) For Extended Release Injectable Suspension for the treatment of...
FDA Approves Lilly's Zyprexa for Two Adolescent Indications
INDIANAPOLIS, Dec. 4 /PRNewswire-FirstCall/ – The U.S. Food and Drug Administration (FDA) today approved Zyprexa (olanzapine) in tablet form as an option for the treatment of schizophrenia and manic...
FDA Medwatch Alert: Zyprexa (olanzapine) - Mar 22, 2004
FDA and Lilly notified healthcare professionals of revision to the WARNINGS section of labeling, describing the increased risk of hyperglycemia and diabetes in patients taking Zyprexa. FDA has asked...
FDA Medwatch Alert: Zyprexa (olanzapine) - May 7, 2002
Eli Lilly notified healthcare professionals of product tampering with Zyprexa, indicated for the treatment of schizophrenia and acute bipolar mania. In a small number of tampering incidents,...
FDA Medwatch Alert: Antipsychotics, Conventional and Atypical
[Posted 06/16/2008] FDA notified healthcare professionals that both conventional and atypical antipsychotics are associated with an increased risk of mortality in elderly patients treated for...
FDA Medwatch Alert: Atypical Antipsychotic Drugs
The Food and Drug Administration has issued a public health advisory to alert health care providers, patients, and patient caregivers to new safety information concerning an unapproved,...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Bipolar Disorder, Major Depressive Disorder, Schizophrenia, Depression